Innovation & Entrepreneurship

“The world should think better about catastrophic and existential risks.” So says a new feature essay in The Economist. Indeed it should, and that includes existential risks associated with emerging technologies.

The primary focus of my research these days revolves around broad-based governance trends for emerging technologies. In particular, I have spent the last few years attempting to better understand how and why “soft law” techniques have been tapped to fill governance gaps. As I noted in this recent post compiling my recent writing on the topic;

soft law refers to informal, collaborative, and constantly evolving governance mechanisms that differ from hard law in that they lack the same degree of enforceability. Soft law builds upon and operates in the shadow of hard law. But soft law lacks the same degree of formality that hard law possess. Despite many shortcomings and criticisms, compared with hard law, soft law can be more rapidly and flexibly adapted to suit new circumstances and address complex technological governance challenges. This is why many regulatory agencies are tapping soft law methods to address shortcomings in the traditional hard law governance systems.

I argued in recent law review articles as well as my latest book, despite its imperfections, I believe that soft law has an important role to play in filling governance gaps that hard law struggles to address. But there are some instances where soft law simply will not cut it. Continue reading →

My thanks to Dr. Wayne Brough, President at Innovation Defense Foundation, for reviewing my new book, Evasive Entrepreneurs and the Future of Governance, over at the AIER website. Brough says of the book:

Adam Thierer has created a thoughtful and surprisingly timely book examining the interplay between entrepreneurs, innovation, and regulators. Thoughtful because he tackles tough questions of innovation and governance in a dynamic market. Timely because the coronavirus pandemic has forced policymakers to seriously reconsider the cumulative regulatory burden and how it may impede the economic recovery. Whether it’s V-shaped or a slower, longer recovery, decades worth of regulatory underbrush has taken its toll on economic activity while providing few, if any, benefits.

He also does a nice job summarizing the key theme of both this latest book and my previous one on Permissionless Innovation:

Thierer takes to task the anti-growth mentality and the political movements against innovation and growth, highlighting the long tradition of hostility toward innovation, from the early 19th-century Luddites up through today’s technophobes advocating restrictions on new technologies such as artificial intelligence. Much of this is driven by the precautionary principle, which Thierer views as an inappropriate guide for regulators. The precautionary principle is a highly risk-averse standard that provides regulators an excuse to stifle innovation for the slightest perceived hazard.

But Dr. Brough rightly takes me to task for not addressing intellectual property issues in either book. He’s right. Continue reading →

In an amazing new MIT Technology Review piece, Antonio Regalado discusses how, “Some scientists are taking a DIY coronavirus vaccine, and nobody knows if it’s legal or if it works.” It is another powerful example of how “citizen-science” and medical self-experimentation (or “biohacking”) is increasingly being used to improve health outcomes, enhance human capabilities, or fight against deadly diseases like COVID. Regalado reports that:

Nearly 200 covid-19 vaccines are in development and some three dozen are at various stages of human testing. But in what appears to be the first “citizen science” vaccine initiative, Estep and at least 20 other researchers, technologists, or science enthusiasts, many connected to Harvard University and MIT, have volunteered as lab rats for a do-it-yourself inoculation against the coronavirus. They say it’s their only chance to become immune without waiting a year or more for a vaccine to be formally approved.

Among those who’ve taken the DIY vaccine is George Church, the celebrity geneticist at Harvard University, who took two doses a week apart earlier this month. The doses were dropped in his mailbox and he mixed the ingredients himself.

Regalado notes that this is all happening despite legal and ethical questions:

By distributing directions and even supplies for a vaccine, though, the Radvac group is operating in a legal gray area. The US Food and Drug Administration (FDA) requires authorization to test novel drugs in the form of an investigational new drug approval. But the Radvac group did not ask the agency’s permission, nor did it get any ethics board to sign off on the plan.

Continue reading →

I was speaking at a virtual conference recently and was discussing my life’s work, which for 30 years has been focused on the importance of innovation and intellectual battles over what we mean progress. I whipped up a short list of some things I have written over just the past 5 years on this topic and thought I would just re-post them here:

UNDERSTANDING THE CHALLENGE WE FACE:

HOW WE MUST RESPOND = “Rational Optimism” / Right to Earn a Living / Permissionless Innovation

Continue reading →

Here’s a new episode of the James Madison Institute “Policy Gone Viral” podcast in which my former Mercatus Center colleague Andrea O’Sullivan and I discuss the future of technological innovation and the public policies governing it. The video is embedded below or you can listen to just the audio here.

This week, it was my pleasure to be interviewed by Eric Peterson of the Pelican Institute on their “PeliCast” live video podcast. We discussed potential futures for permissionless innovation and, more importantly, what my favorite beer in Louisiana is. Tune in to find the answer!

 

Marc Andreessen is interviewed by Sriram Krishan in his new newsletter, The Observer Effect, and asked what motivates him to support technological innovation and “to go read up on a new topic every day” related to tech and progress. His answer is inspirational and perfectly encapsulates why I also have made technological progress the focus of my life’s work:

I am a deep believer in – after learning a lot over the years about economic history and of cultural history – that technology really is the driver. There were basically millennia of just subsistence farming industry and all of a sudden, there was this vertical takeoff a few hundred years ago. And quality of life exploded around the world. Not evenly but starting in Europe and expanding out. It’s basically all technology. It’s always the printing press, it’s the internet and on and on. And you get this incredible upward trajectory. We have the potential over the course of the next century or over the next few centuries to really dramatically advance and have life be better for virtually everybody. Technology is quite literally the lever for being able to take natural resources and able to make something better out of them.

And so it’s just it’s the most interesting and by far the most useful and the most beneficial thing I can think of doing.

Amen, brother! I devoted my last two books (Permissionless Innovation and Evasive Entrepreneurs) and all my life’s work, to proving that exact point. Also, I really like Andreessen’s definition of technology as, “the lever for being able to take natural resources and able to make something better out of them.” I’ve added that to my running compendium, “Defining Technology,” which features various definitions of technology.

 

Here’s a webinar video of a discussion I had recently with Kevin Gomez and his colleague at the Institute for Economic Inquiry at Creighton University’s School of Business.  We discussed my new book, Evasive Entrepreneurs and the Future of Governance: How Innovation Improves Economies and Governments and the future of “permissionless innovation” more generally. My thanks to Kevin and his team at Creighton for inviting me to join them for a fun discussion. Topics include:

  • why evasive entrepreneurialism is expanding
  • the growth of innovation arbitrage
  • the difference between technologies that are “born free” versus “born in captivity”
  • the nature of “the pacing problem” and what it means for policy
  • the problem with “set-it-and-forget-it” & “build-and-freeze” regulations
  • technological risk and the potential for “soft law” governance
  • sensible legislative reforms to advance permissionless innovation (such as “the innovator’s presumption” and “the sunsetting imperative”)
  • how the COVID crisis potentially opens the Overton Window to much-needed policy change

DIY medicineMargaret Talbot has written an excellent New Yorker essay entitled, “The Rogue Experimenters,” which documents the growth of the D.I.Y.-bio movement. This refers to the organic, bottom-up, citizen science movement, or “leaderless do-ocracy” of tinkerers, as she notes. I highly recommend you check it out.

As I noted in my new book on Evasive Entrepreneurs and the Future of Governance, “DIY health services and medical devices are on the rise thanks to the combined power of open-source software, 3D printers, cloud computing, and digital platforms that allow information sharing between individuals with specific health needs. Average citizens are using these new technologies to modify their bodies and abilities, often beyond the confines of the law.”

Talbot discusses many of the same examples I discuss in my book, including:

  • the Four Thieves Vinegar collective, which devised instructions for building its own version of the EpiPen;
  • e-nable, an international collective of thirty thousand volunteers, designs and 3-D-prints prosthetic hands and arms (and which has, more recently, distributed more than fifty thousand face shields in more than twenty-five countries.);
  • GenSpace and other community biohacking labs; and
  • Open Insulin and Open Artificial Pancreas System.

I like the way Talbot compares these movements to the hacker and start-up culture of the Digital Revolution: Continue reading →

Matt RidleyThere are few things more exciting to innovation policy geeks that than the week a new Matt Ridley book drops. Thankfully, that time is upon us once again. This week, Ridley’s latest book, How Innovation Works: And Why It Flourishes in Freedom, is being released. I can’t wait to dig in.

This weekend, the Wall Street Journal published an essay condensed from the book entitled, “Innovation Can’t Be Forced, but It Can Be Quashed.” Here are some of the highlights from Ridley’s piece:

Innovation relies upon freedom to experiment and try new things, which requires sensible regulation that is permissive, encouraging and quick to give decisions. By far the surest way to rediscover rapid economic growth when the pandemic is over will be to study the regulatory delays and hurdles that have now been hastily swept aside to help innovators in medical devices and therapies, and to see whether such reforms could be applied to other parts of the economy too.

Dealing with Covid-19 has forcibly reminded governments of the value of innovation. But if we are to get faster vaccines and treatments—and better still, more innovation across all fields in the future—then innovators need to be freed from the shackles that hold them back.

These are crucial point, and ones I discuss in the launch essay and the afterward of my new book, Evasive Entrepreneurs and the Future of Governance. Alas, as I pointed out in that launch essay and my last book on Permissionless Innovation, a great many barriers stand in the way of the freedom to experiment and try new things. As Ridley points out: Continue reading →